UNICEF Quality Assurance in the procurement of medicines

Size: px
Start display at page:

Download "UNICEF Quality Assurance in the procurement of medicines"

Transcription

1 UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION

2 Today s presentation addresses 3 questions: How is UNICEF involved in quality assurance of essential medicines What does UNICEF check before it enters into a contract with a supplier What does UNICEF check after it enters into a contract with a supplier 2

3 Quality Assurance cover the following tasks Receipt of Goods and GMP inspections Non-pharmaceuticals Pharmaceuticals Financial evaluation of suppliers Vendor Master / UNGM Receipt of bids / tabulation of offers Quality System 3

4 UNICEF s quality system is based on: Division and Centre Procedures Available electronically on the UNICEF intranet ISO 9000:2001 to be implemented Quality System for GMP inspections in accordance with PIC-S Quality System requirements for GMP inspectorates WHO Model QA system for Procurement to be implemented 4

5 Today s presentation addresses 3 questions: Conclusion (1) UNICEF has a well established Quality Assurance System in place What does UNICEF check before we contract a supplier 5

6 Pre-qualification - Pharmaceuticals Suppliers Review of documentation Good Manufacturing Practice (GMP) inspections to ensure compliance with WHO GMP guidelines Products Product Questionnaire as in Model QA System WHO TRS 937 6

7 Pre-qualification of suppliers How? Technical questionnaire Manufacturing site Dosage forms Export experience License to manufacture pharmaceuticals Is a GMP inspection needed? 7

8 GMP inspections Decision based on the regulatory environment in country of origin GMP inspection by UNICEF or a representative selected by UNICEF Contract Manufacture only accepted if sub-contractor also is approved by UNICEF 8

9 GMP inspections by UNICEF To check compliance with WHO GMP Guidelines Primarily done by UNICEF staff 102 GMP inspections carried out in companies failed (37 %) Detailed GMP inspection report forwarded to company with request to respond within 1 month 9

10 GMP inspections collaborations Local authority invited to participate Joint inspections with WHO UNICEF is an observer to the Pharmaceutical Inspection Cooperation Scheme (PIC-S) 10

11 Pre-qualification of products Done in connection with Invitation to Bid (ITB) by the HIV / Health Center (HHC) Company to complete questionnaire and forward supporting documentation Supply Agreement with best offer 1-2 back-up suppliers 11

12 Pre-qualification of suppliers of Vaccines, HIV/AIDS, malaria and TB products Products must be pre-qualified by WHO and listed on the WHO website Supplier has confirmed to UNICEF that products are identical to those assessed by WHO/UNICEF UNICEF s purchase is traced in WHO/UNICEF GMP inspections. 12

13 Today s presentation addresses 3 questions: Conclusion (1): Conclusion (2): Quality Assurance has a team of professionals and a well documented quality system Quality Assurance focuses on identifying supplier and product quality before we sign the first contract What does UNICEF check after it enters into a contract with a supplier 13

14 QAC is performing the following activities after we contract a supplier Supply Division licensed by the Danish Medicines Agency (DMA) to wholesale pharmaceutical products to handle narcotic or psychotropic substances Compliance with European Union guidelines on Good Distribution Practice (GDP) 14

15 GDP ensures Quality system implemented Organisation defined Training of personnel in GDP Adequate facilities Written procedures Records of purchase and sale Self-inspections performed Recalls can be carried out 15

16 Products received in the warehouse are always quality inspected Visual inspection Product Dosage form and strength Quantity Certificate of analysis Satisfactory remaining shelf-life? Was it manufactured by the approved site? 16

17 Quality control testing Analysis performed on a random basis according to an annual plan Analysis performed by Therapeutic Goods Administration, Australia and USP, USA Collaboration with WHO on testing of HIV/AIDS products 17

18 Quality control of direct shipments Pre-delivery inspections - Third party - Country Office Review of packing list and Certificate of Analysis Random quality control testing in accordance with prior experience 18 18

19 Quality Assurance is bringing you quality products from premium suppliers Conclusion (1): Conclusion (2): Conclusion (3): Quality Assurance has a team of professionals and a well documented quality system Quality Assurance are spending many resources on securing supplier and product quality before we sign the first contract Quality Assurance closely and continuously monitors the performance of our suppliers 19

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

UNICEF Requirements for RUTF Manufacturers

UNICEF Requirements for RUTF Manufacturers UNICEF Requirements for RUTF Manufacturers Jan Komrska in collaboration with Quality Assurance Center Consultation with RUTF Suppliers Copenhagen, 18th October, 2010 Today s presentation addresses 3 questions:

More information

Contents. 1. Certification of Materials 2. Supply of Materials

Contents. 1. Certification of Materials 2. Supply of Materials September 2013 1 Contents 1. Certification of Materials 2. Supply of Materials 2 1. CERTIFICATION OF MATERIALS The European standard which specifies the different types of inspection documents supplied

More information

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016

New GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016 New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised

More information

Session 4: Ensuring Product Quality Throughout the Supply Chain

Session 4: Ensuring Product Quality Throughout the Supply Chain Session 4: Ensuring Product Quality Throughout the Supply Chain Potential Quality Assurance Checkpoints Within the Overall Supply Chain 1. Raw Materials / Components 2. Manufacturing 3. Packaging 6. Receiving

More information

Session 1: Prequalification and Procurement

Session 1: Prequalification and Procurement Session 1: Prequalification and Procurement Session Objectives Discuss aims of the World Health Organization (WHO) Prequalification Programme Explain the role of the United Nations Population Fund (UNFPA)

More information

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides

GMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics

More information

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION

QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction

More information

Pharmaceutical product technical requirements and the Interagency pharmaceutical product questionnaire

Pharmaceutical product technical requirements and the Interagency pharmaceutical product questionnaire Pharmaceutical product technical requirements and the Interagency pharmaceutical product questionnaire Atieno Ojoo Technical specialist, Pharmaceuticals UNICEF Supply Division 20 th October 2008, UNICEF

More information

Model Quality Assurance System for procurement agencies. What it means for manufacturers?

Model Quality Assurance System for procurement agencies. What it means for manufacturers? Model Quality Assurance System for procurement agencies. What it means for manufacturers? JOINT UNICEF, UNFPA & WHO MEETING WITH MANUFACTURERS AND SUPPLIERS OF DIAGNOSTIC PRODUCTS, FINISHED PHARMACEUTICAL

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM

GMP Inspection Process. Types of GMP Inspection. Module 18 Slide 1 of 14 WHO - EDM GMP Inspection Process Types of GMP Inspection Module 18 Slide 1 of 14 WHO - EDM Objectives 1. To review the different types of inspection 2. To examine when each is appropriate 3. To discuss inspections

More information

INVESTING IN CHILDREN

INVESTING IN CHILDREN INVESTING IN CHILDREN SUPPLY SOLUTIONS FROM PROCUREMENT SERVICES Introduction UNICEF is dedicated to protecting children s rights by helping meet their basic needs and expanding their opportunities - so

More information

Data Collection Tools Functions, Indicators & Sub-Indicators

Data Collection Tools Functions, Indicators & Sub-Indicators Data Collection Tools 27- Functions, Indicators & A. National regulatory system Indicator RS1: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function

More information

Guidelines for the international procurement of vaccines and sera

Guidelines for the international procurement of vaccines and sera WHO/VSQ/98.05 ORIGINAL: ENGLISH DISTR.: GENERAL Guidelines for the international procurement of vaccines and sera GLOBAL PROGRAMME FOR VACCINES AND IMMUNIZATION VACCINE SUPPLY AND QUALITY World Health

More information

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible

More information

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL

More information

Revised Global Fund Quality Assurance Policy for Pharmaceutical Products and Price &Quality Reporting

Revised Global Fund Quality Assurance Policy for Pharmaceutical Products and Price &Quality Reporting Revised Global Fund Quality Assurance Policy for Pharmaceutical Products and Price &Quality Reporting AIDS Medicines and Diagnostics Services (AMDS) Partners and Stakeholders Meeting, Board Decision on

More information

What we do. UNICEF Supply Division s work is a direct input to development programmes and emergency response

What we do. UNICEF Supply Division s work is a direct input to development programmes and emergency response Supply Division What we do UNICEF Supply Division s work is a direct input to development programmes and emergency response Effective, efficient supply operation for programmes Expertise on strategic-essential

More information

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management

Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical

More information

2012 Joint Guideline Launch

2012 Joint Guideline Launch Behind the development - CHC s Guideline for Raw Materials Behind the development - ASMI s Good Supplier Practice Why develop these guidelines? Quality of starting materials and vendor assurance (VA) of

More information

Cold Chain Committee Guidance for shippers, transport service providers and subcontractors

Cold Chain Committee Guidance for shippers, transport service providers and subcontractors Guidance for shippers, transport service providers and subcontractors involved in the distribution of pharmaceutical products registered for storage between 2 and 8 Celsius Guidance for Shippers 1 of 7

More information

Control of veterinary products and vaccines Inspection system, monitoring plan, monitoring of vaccines distribution

Control of veterinary products and vaccines Inspection system, monitoring plan, monitoring of vaccines distribution Workshop for OIE national Focal Points for Veterinary Products (2 nd cycle) Vienna (Austria), 20-22 November 2012 Control of veterinary products and vaccines Inspection system, monitoring plan, monitoring

More information

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017

Phase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/

More information

Session 13: Prequalification Within the Context of Global Fund Procurements

Session 13: Prequalification Within the Context of Global Fund Procurements Session 13: Prequalification Within the Context of Global Fund Procurements Established in 2002 Global Fund Attracts and disburses additional resources to prevent and treat AIDS, tuberculosis (TB), and

More information

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018

PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME. PI July 2018 PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 045-1 1 July 2018 GUIDELINES ON THE FORMALISED RISK ASSESSMENT FOR ASCERTAINING THE APPROPRIATE GOOD MANUFACTURING

More information

Quality assurance for essential medicines and health products. IPC meeting: December 2012

Quality assurance for essential medicines and health products. IPC meeting: December 2012 Quality assurance for essential and health products IPC meeting: December 2012 Pharmaceutical Products QA Policy (June 2009) December 2010: requirements to purchase ACTs FDC in priority Condoms Procurement

More information

Session 5: Increase in Use of the WHO Prequalification Programme

Session 5: Increase in Use of the WHO Prequalification Programme Session 5: Increase in Use of the WHO Prequalification Programme Perceived Need for Prequalification In an ideal world: Regulated pharmacies and service providers would supply medicines to clients Regulatory

More information

Good Procurement Practices for artemisinin-based antimalarial medicines

Good Procurement Practices for artemisinin-based antimalarial medicines Good Procurement Practices for artemisinin-based antimalarial medicines AMDS Partners and Stakeholders Meeting Geneva, 23 March 2010 Silvia Schwarte Medicines and Diagnostics Unit Global Malaria Programme

More information

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009

European Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009 European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)

UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) A. Background January 2019 UNICEF Technical requirements for Medical Devices are the requirements that suppliers need to comply with, and that products

More information

Introduction of new suppliers to UNICEF procurement mechanisms

Introduction of new suppliers to UNICEF procurement mechanisms UNICEF/PFPG2015-2253/Lynch Introduction of new suppliers to UNICEF procurement mechanisms Vaccine Industry Consultation 2017 Outline Supplier Registration Supplier Performance Monitoring Requirements for

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

V. S. International Pvt. Ltd

V. S. International Pvt. Ltd V. S. International Pvt. Ltd Innovation in medicine Partners In human care for today and tomorrow... Unit I - Daman V. S. International is a Healthcare Company with it s Corporate Head office at Mumbai,

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS ANNEX 13 MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS Introduction Medicinal products intended for research and development trials are not at present subject either to marketing or manufacturing Community

More information

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry

Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry 1 Presentation Outline Pharmaceutical Quality Management Partner Selection and Qualification Shipping Qualification

More information

Procurement Capacity Toolkit

Procurement Capacity Toolkit Procurement Capacity Toolkit A. Introduction Overview of B. Modules of the Procurement Capacity Toolkit C. Supplementary Topics D. Summary Guide for Policymakers, Ministry Personnel, and Program Managers

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Finished Pharmaceutical Product Questionnaire This questionnaire is used to collect information from vendors with regards to finished pharmaceutical products

More information

GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd

GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master

More information

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire

GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE QA.APP.GEN-52 Laboratory Commodities and Consumables: Supplier Technical Questionnaire GLOBAL HEALTH SUPPLY CHAIN QUALITY ASSURANCE Laboratory Commodities and Consumables: Supplier Technical Questionnaire This questionnaire is used to collect information from offerors of Laboratory Commodities

More information

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment

On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment On Approval of the Rules on Importation and Exportation of Medicines, Products of Medical Purposes and Medical Equipment Resolution of the Government of the Republic of Kazakhstan No. 711 of 31 May 2012

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND

More information

Inspection of API Manufacturers & Update on Registration Process

Inspection of API Manufacturers & Update on Registration Process Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers

More information

Management System Hilton Olympia, London 13 th February 2013

Management System Hilton Olympia, London 13 th February 2013 14. Building A Robust Quality Management System Hilton Olympia, London 13 th February 2013 Calcott Consulting consultant to the pharmaceutical & biotechnology industry Presenter s note Please note, the

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

Supplier questionnaire. 1. Organisation Details (Mandatory) Quality Department Details (or representative)

Supplier questionnaire. 1. Organisation Details (Mandatory) Quality Department Details (or representative) In order to register your organisation as an approved supplier on our List of Approved Suppliers in accordance with the requirements of our Quality Management System, ISO9001 and AS9120 standards as revised,

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

INTERCOUNTRY COOPERATION IN SUPPLY OF ESSENTIAL DRUGS

INTERCOUNTRY COOPERATION IN SUPPLY OF ESSENTIAL DRUGS REGIONAL COMMITTEE Provisional Agenda item 11 Fifty-second Session 25 June 1999 INTERCOUNTRY COOPERATION IN SUPPLY OF ESSENTIAL DRUGS CONTENTS Page 1. INTRODUCTION 1 2. MANAGING DRUG SUPPLY 1 3. EXISTING

More information

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Prequalification of Medicines Programme SOP 408.4 Annex B WHO PUBLIC INSPECTION REPORT API Manufacturer Part 1: General information Name of Manufacturer Unit number WHO PUBLIC INSPECTION REPORT (WHOPIR)

More information

UNICEF Supply Division Copenhagen. Quality Assurance

UNICEF Supply Division Copenhagen. Quality Assurance UNICEF Supply Division Copenhagen Quality Assurance Quality Assurance Centre Chief QAC Assistant Quality Inspection Unit Pharmaceuticals Quality Inspection Unit Non Pharma Supplier Evaluation Unit Bids

More information

Vendor Qualification Survey

Vendor Qualification Survey 1200 West 96 th St Minneapolis, MN 55431 Ph: 952-888-7900 Fax: 952-888-2719 Vendor Qualification Survey Vendor Information Company Name: Date: Address: City: Phone Number: email address: Product or Service

More information

Supplier Quality Survey

Supplier Quality Survey Supplier Quality Survey Smiths Interconnect Lorch Microwave assumes a basic responsibility for the quality of all contract end items produced under its direction. Since the quality of purchased and sub-contracted

More information

SUPPLIERS QUALIFICATION

SUPPLIERS QUALIFICATION SUPPLIERS QUALIFICATION With each passing day, new suppliers and manufacturers of packaging materials, raw materials, laboratories, etc., appear, offering products and services of different quality levels.

More information

CLICK TO ADD TITLE [SPEAKERS NAMES]

CLICK TO ADD TITLE [SPEAKERS NAMES] CLICK TO ADD TITLE [SPEAKERS NAMES] [DATE] Thanks to our generous sponsors Increasing access to essential medicines through pre-qualified, quality local sources Stephen Kimatu Partnership for Supply Chain

More information

Quality Quality problems r API used used in essent essen ial t ial medicines : Role e of of WHO and and its its pre pr lifi qua ca i ttion on progr

Quality Quality problems r API used used in essent essen ial t ial medicines : Role e of of WHO and and its its pre pr lifi qua ca i ttion on progr Quality problems for API used in essential medicines : Role of WHO and its pre qualification programme Corinne POUGET Consultant Pavia 11 May 2012 1 A few key figures 2010 WW Pharmaceutical market: a USD

More information

NQA-1 Graded Approach, 55-Gallon Drum Summary

NQA-1 Graded Approach, 55-Gallon Drum Summary 1, Organization 2, Quality Assurance program 3, Design 4, Procurement Document 5, Instructions, procedures, and Drawings 100 Basic 200 Structure and Responsibility 201 General 202 Delegation of Work 300

More information

Good Distribution Practice and Supply Chain Risk Evaluation

Good Distribution Practice and Supply Chain Risk Evaluation Good Distribution Practice and Supply Chain Risk Evaluation Who we are - Exelsius An international consultancy established in 2007 bringing cross-sector expertise and skills into a range of services designed

More information

UNICEF s Procurement Processes and Tendering for Diagnostics

UNICEF s Procurement Processes and Tendering for Diagnostics UNICEF s Procurement Processes and Tendering for Diagnostics Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers UN City, Copenhagen Presented by: Lama Suleiman 23 September 2014 Contracts

More information

Training manual: licensing, lot release, laboratory access

Training manual: licensing, lot release, laboratory access WHO/V&B/01.16 ORIGINAL: ENGLISH DISTR.: GENERAL Training manual: licensing, lot release, laboratory access DEPARTMENT OF VACCINES AND BIOLOGICALS World Health Organization Geneva 2001 The Department of

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection

Annex 4. Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection Annex 4 Assessment tool based on the model quality assurance system for procurement agencies: aide memoire for inspection 1. Introduction 294 2. Purpose 294 3. Scope 294 4. Assessment tool 295 293 WHO

More information

Issues related to procurement of nutrition products

Issues related to procurement of nutrition products Issues related to procurement of nutrition products Jan Komrska Nutrition Unit Medicines and Nutrition Centre Suppliers Meeting, 3 & 4 October 2011, Copenhagen OUTLINE Major developments since last meeting

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency

DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Introduction to EU Regulatory system and GMP Inspection system. The Qualified Person. DJ Cockburn Head of Manufacturing and Quality Compliance European Medicines Agency Any views expressed may not necessarily

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Development of contract manufacturing on the example PJSC «Pharmimex»

Development of contract manufacturing on the example PJSC «Pharmimex» Development of contract manufacturing on the example PJSC «Pharmimex» Inga Aleksandrovna NIZHARADZE, Vice-President of PJSC «Pharmimex» www.pharmimex.com +7 (495) 692-48-48 www.skopinpharm.com +7 (49156)

More information

SUPPLIER QUALITY REQUIREMENTS

SUPPLIER QUALITY REQUIREMENTS SUPPLIER QUALITY REQUIREMENTS TABLE OF CONTENTS 1) PURPOSE PG 2 2) KINNEAR PURCHASE ORDER PG 2 3) USE AND COMMUNICATION PG 2 4) SUPPLIER APPROVAL PG 2 5) GENERAL REQUIREMENTS PG 3 SQD Rev 2 2014-08-13

More information

Validation Requirements for Nutrition Products

Validation Requirements for Nutrition Products DC1 Validation Requirements for Nutrition Products Supply Division Dimitris Catsoulacos Quality Assurance Specialist UNICEF Supply Division Nutrition Supplier Meeting 14-16 June 2017, Copenhagen Slide

More information

Supplier Assurance Program. CBE Pty Ltd

Supplier Assurance Program. CBE Pty Ltd Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

Session 2: Overview of the WHO Prequalification Programme for Condoms

Session 2: Overview of the WHO Prequalification Programme for Condoms Session 2: Overview of the WHO Prequalification Programme for Condoms Session Objectives Introduce the key differences between the new and old WHO/UNFPA prequalification scheme Understand the required

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer

Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer Waiting for Eurasian Union GMP inspection. Gap-analysis from the point of view of the Russian manufacturer Maklakova Olga, Quality director Kazan, 2018 Facilities 1 solid formsworkshop 1 semi-solid formsworkshop

More information

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products

Overview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand

More information

Procurement and Supply Management of Pharmaceuticals and other Health Products.

Procurement and Supply Management of Pharmaceuticals and other Health Products. Procurement and Supply Management of Pharmaceuticals and other Health Products. 13 December 2007 Stop TB workshop on Global Fund grant negotiation and implementation Sophie Logez PSM Team Objectives Describe

More information

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working

More information

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products

Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Date: April 23, 2012 Appropriate Control Strategies Eliminate the Need for Redundant Testing of Pharmaceutical Products Key Messages Importation quality control testing for pharmaceutical, biological/biotechnology

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

GMP Track 1 Day 2 Session 1 Vendor Assurance

GMP Track 1 Day 2 Session 1 Vendor Assurance GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics

More information

ANMAT Order No 5260/2008

ANMAT Order No 5260/2008 ANMAT Order No 5260/2008 HAVING REGARD TO Laws Nos 16.463, 17.818, 19.303; Decrees Nos 9763/64, 150/92, 1890/92, 177/93; Joint Resolutions Nos 268/92 (M.S. and A.S.) and 470/92 (M.E. and O.S.P.) and No

More information

INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION

INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION Part A: Details of the market Authorization holder (local agent)- 1. Name of Company: 2. Address and contact details of the company : 3. a)

More information

PIC/S Assessment & Joint Reassessment Programme REVISED PIC/S AUDIT CHECKLIST

PIC/S Assessment & Joint Reassessment Programme REVISED PIC/S AUDIT CHECKLIST PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2005 (Rev. 2) Annex 20 September 2012 PIC/S Assessment & Joint Reassessment Programme REVISED PIC/S AUDIT CHECKLIST

More information

WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT

WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT WHY UNITAID MATTERS FOR PEOPLE LIVING WITH HIV/AIDS, TB AND MALARIA MARKET IMPACT by the Civil Society Delegations to UNITAID PROBLEM SOLUTION MARKET JOURNEY GOAL 1 No appropriate product Product adapted

More information

ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS

ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS ANNEX 5 PRODUCT SPECIFICATIONS AND TECHNICAL REQUIREMENTS This Document is to provide the offerors with the product(s) specifications and Technical Requirements for The Procurement of the commodities listed

More information

Feedback from Inspection Programme

Feedback from Inspection Programme Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme TB Alliance Open Forum 4 Key Issues in TB Drug Development Wondiyfraw Z. Worku Technical officer August 18-19, 2010 Addis Ababa, Ethiopia Out line Brief intro to

More information

Supplies and Reagents

Supplies and Reagents Supplies and Reagents PACT Workshop: Design & Operation of GMP Cell Therapy Facilities April 10 th -11 th, 2007 NHLBI-sponsored PACT Group Guidance for Industry INDs Approaches to Complying with CGMP During

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Ref. Ares(2013)148102-05/02/2013 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013)179367

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments

More information

Guide to Scientific and Regulatory Advice for GXP activities

Guide to Scientific and Regulatory Advice for GXP activities Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

Overview sulla nuova guideline GDP

Overview sulla nuova guideline GDP AFTI 09 febbraio 2012 Overview sulla nuova guideline GDP Fabio Dotto Ispettorato Regionale Medicamenti Svizzera del Sud 1 113 GDP Guidelines GDP of Medicinal Products for Human Use Public consultation

More information

Orange and Yellow Guides

Orange and Yellow Guides PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING FIELD? Dr. Alison M.Beaney Regional Quality Assurance Specialist North-East England PHARMACY PREPARATION ACROSS EUROPE IS THERE A LEVEL PLAYING

More information